Time in Range (TIR): How It Works, Accuracy, and When to

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Time in Range (TIR) is the percent of CGM readings within the target range — typically 70 to 180 mg/dL — over a defined period (usually 14 days).
  • The Battelino 2019 international consensus targets are TIR greater than 70 percent for most adults with type 1 or type 2 diabetes, greater than 50 percent for older or high-risk adults, and tighter targets in pregnancy.
  • TIR correlates with A1C (about 70 percent TIR is roughly an A1C of 7 percent) but captures variability and hypoglycemia that A1C cannot.
  • Re-analyses of the DCCT/EDIC data show TIR strongly predicts microvascular complications independent of A1C.
  • TIR is best interpreted alongside Time Below Range (TBR — target less than 4 percent) and Time Above Range (TAR — target less than 25 percent).

Time in Range (TIR) is the percent of CGM readings within the target glucose range — typically 70 to 180 mg/dL — over a 14-day window. The international consensus target for most adults with type 1 or type 2 diabetes is greater than 70 percent. TIR is now considered a primary outcome alongside A1C in diabetes care.

How TIR Is Calculated

  • Every 1 to 5 minutes, the CGM records a glucose value (the exact interval depends on the device).
  • Over a defined window (usually 14 days), the software counts how many of those readings fall within 70 to 180 mg/dL.
  • That count is divided by the total number of readings and expressed as a percent.
  • Minimum 70 percent sensor wear (about 10 of 14 days) is required for the calculation to be reliable.
  • Time below range (TBR) and time above range (TAR) are calculated similarly — they always sum to 100 percent with TIR.

The standard target range (70 to 180 mg/dL) was chosen by international consensus in 2019 — it captures the range where most short- and long-term harm is avoided.

Battelino 2019 Consensus Targets

Population Target Range TIR Goal TBR (<70) TAR (>180)
T1D and T2D, non-pregnant adults 70 to 180 mg/dL >70% <4% <25%
Older or high-risk adults 70 to 180 mg/dL >50% <1% <50%
Pregnancy with T1D 63 to 140 mg/dL >70% <4% <25%
Pregnancy with T2D or GDM 63 to 140 mg/dL >85% <4% <10%

The lower target (greater than 50 percent) for older or high-risk adults reflects the trade-off between glucose control and hypoglycemia risk — a hypo event in an older adult is far more dangerous than mild hyperglycemia.

Time Below Range and Time Above Range

Metric Threshold Target Clinical Meaning
TBR level 1 <70 mg/dL <4% (about 1 hour/day) Mild hypoglycemia
TBR level 2 <54 mg/dL <1% (15 min/day) Clinically significant hypoglycemia
TAR level 1 >180 mg/dL <25% (6 hours/day) Mild hyperglycemia
TAR level 2 >250 mg/dL <5% (about 1 hour/day) Significant hyperglycemia; complications risk

TBR is the safety metric. A high TIR achieved with elevated TBR (frequent lows) is not a safe configuration. Reduce TBR first, then push TIR higher.

TIR vs A1C: Rough Conversion

TIR (%) Mean Glucose (mg/dL) Approximate A1C (%)
90 140 6.5
80 155 7.0
70 170 7.5
60 185 8.0
50 200 8.5
40 215 9.0

Each 10 percent increase in TIR is roughly equivalent to a 0.5 percent decrease in A1C. The relationship is not exact — variability matters. Two people with the same TIR can have different mean glucose and different A1C if one has more swings.

Why TIR Matters Independently of A1C

  • Captures variability: someone with average glucose 170 mg/dL but swinging 60 to 280 has the same A1C as someone steady at 170, but very different physiology.
  • Captures hypoglycemia: A1C cannot detect lows; TBR can.
  • Predicts complications: Beck and colleagues re-analyzed the DCCT/EDIC trial and found TIR independently predicts retinopathy and microalbuminuria.
  • Patient-actionable: a daily TIR percent is easier to act on than a quarterly A1C number.
  • Faster feedback: 14-day window vs 3-month window.

When to Use TIR

  • Anyone using a CGM — automatically calculated in AGP reports.
  • Type 1 diabetes — primary tracking metric alongside hypoglycemia frequency.
  • Type 2 diabetes on insulin or sulfonylurea — captures lows A1C misses.
  • Pregnancy — when tight control is needed and quick feedback matters.
  • Hospital and post-hospital periods — when therapy adjustments happen rapidly.
  • Hemoglobinopathies — when A1C is unreliable.
  • Anemia, recent transfusion, EPO use — when A1C is biased.

How to Improve TIR

Strategy Typical TIR Impact
Consistent meal timing and carb counting +10 to 15%
Pre-meal insulin timing (15 min before) +5 to 10%
Automated insulin delivery (AID) +10 to 20%
Lower-carb / lower-GI diet +10 to 15%
Post-meal walking (10 to 20 min) +5 to 10%
Address dawn phenomenon +3 to 8% (overnight)
Reduce overnight hypoglycemia +5 to 10% (and safer)

Common TIR Patterns and What They Mean

  • Low TIR, high TAR, low TBR: too much hyperglycemia — increase insulin, reduce carbs, add medication.
  • Moderate TIR, high TBR: overcorrecting — reduce insulin doses, adjust basal rate.
  • Low TIR, high TAR and TBR: high variability — focus on consistent timing, AID, smaller meal carbs.
  • High TIR, low TBR: well controlled — maintain.
  • Stable TIR but rising A1C: check for hemoglobinopathy or CGM sensor bias.

Limitations of TIR

  • Requires CGM use with adequate sensor wear (≥70 percent).
  • Does not directly measure variability (CV or MAGE do that).
  • Reference range (70 to 180) is standardized; some clinicians use tighter ranges (e.g., 70 to 140).
  • Sensor accuracy declines in the first 24 hours and at extremes of glucose.
  • Not all insurance covers CGM for type 2 diabetes not on insulin.
  • 14-day snapshots may miss longer-term patterns.

TIR is one of several CGM metrics that work together. See GMI vs A1C, coefficient of variation for glucose, MAGE and glucose variability, and the Ambulatory Glucose Profile. For background on glucose averages and A1C, see A1C levels.

The Bottom Line

Time in Range is the percent of CGM readings within 70 to 180 mg/dL over a 14-day window. Target greater than 70 percent for most adults; greater than 50 percent for older or high-risk patients; tighter for pregnancy. Always interpret TIR alongside Time Below Range (target less than 4 percent below 70) and Time Above Range. Roughly, every 10 percent gain in TIR equals about 0.5 percent A1C reduction. TIR captures variability and hypoglycemia that A1C misses and predicts complications independently. If you wear a CGM, look at your TIR weekly — it is the most actionable single number in modern diabetes care.

Frequently Asked Questions

What is a good time in range for diabetes?

For most non-pregnant adults with type 1 or type 2 diabetes, the target is greater than 70 percent of CGM readings within 70 to 180 mg/dL — about 16 hours 48 minutes per day. For older adults or those at high risk of hypoglycemia, greater than 50 percent is acceptable. Pregnant women with type 1 diabetes target greater than 70 percent within a tighter 63 to 140 mg/dL range. Pregnancy with type 2 or gestational diabetes targets greater than 85 percent.

How does time in range compare to A1C?

TIR and A1C correlate but are not interchangeable. About 70 percent TIR usually corresponds to an A1C around 7 percent; 50 percent TIR is around 8 percent; 90 percent TIR is near 6 percent. A1C reflects the average glucose over 3 months but misses variability and hypoglycemia. TIR reflects 14 days of actual exposure and shows how stable that glucose was. Both have value — TIR for day-to-day management, A1C for cross-sectional measurement.

How many days of CGM data do you need to calculate TIR?

The consensus minimum is 14 days of CGM use with at least 70 percent sensor wear — about 10 of those 14 days. Shorter windows are less reliable and may miss day-to-day variability. Some clinics now use 30-day windows for greater accuracy at the expense of timeliness. Your CGM software (Dexcom Clarity, FreeStyle LibreView, etc.) calculates this automatically.

Is high time in range always good?

Usually yes, but not always. A TIR of 95 percent with frequent hypoglycemia (high TBR) is not better than a TIR of 75 percent with no lows. Always interpret TIR alongside Time Below Range — TBR below 70 should be less than 4 percent, and TBR below 54 should be less than 1 percent. High TIR achieved at the cost of hypoglycemia is not a safe target.

Sources

  1. Recommendations From the International Consensus on Time in Range. Diabetes Care 42(8):1593-1603, 2019.
  2. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care 47(Suppl 1).
  3. Beck RW, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care 42(3):400-405, 2019.